1-9 of 9
Bruce D. Cheson, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Utility Of 18 f-FDG PET/CT In Assessing Bone Marrow Involvement In Lymphoma

Chaitra S. Ujjani, MD, Elizabeth Hill, MD, Samer Nassif, MD, Hongkun Wang, PhD, Yiru Wang, BS, Metin Ozdemirli, MD, Giuseppe Esposito, MD, Bruce D. Cheson, M.D.
Journal: Blood
Blood (2013) 122 (21): 2981.
https://doi.org/10.1182/blood.V122.21.2981.2981
Published: 2013
Journal Articles

Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)

Noreen Fulton, B.S., Jeffrey Johnson, M.S., Lawrence D. Kaplan, M.D., Greg Koval, B.S., Greg Malnassy, B.S., Sin-Ho Jung, Ph.D., Steve Devine, M.D., Thomas C. Shea, M.D., John P. Leonard, M.D., Bruce D. Cheson, M.D., Wendy Stock, M.D.
Journal: Blood
Blood (2013) 122 (21): 3002.
https://doi.org/10.1182/blood.V122.21.3002.3002
Published: 2013
Journal Articles

Final Results Of a Phase I Study Of The Anti-CD22 Antibody-Drug Conjugate (ADC) DCDT2980S With Or Without Rituximab (RTX) In Patients (Pts) With Relapsed Or Refractory (R/R) B-Cell Non-Hodgkin’s Lymphoma (NHL)

Ranjana Advani, MD, Andy I. Chen, MD, PhD, Daniel Lebovic, MD, Mark W. Brunvand, MD, Andre Goy, MD, Julie E. Chang, MD, Ephraim Hochberg, Sreeni Yalamanchili, BSPharm, Robert Kahn, Dan Lu, Akiko Chai, MS, Yu-Waye Chu, Bruce D. Cheson, M.D.
Journal: Blood
Blood (2013) 122 (21): 4399.
https://doi.org/10.1182/blood.V122.21.4399.4399
Published: 2013
Journal Articles

Evaluation Of a Novel 3 Factor Prognostic Score (PS-3) For Patients With Advanced Hodgkin Lymphoma (HL) Treated On US Intergroup E2496

Catherine S. Diefenbach, MD, Hailun Li, MS, Fangxin Hong, PhD, Leo I. Gordon, MD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Michael Crump, MD FRCPC, Randy D. Gascoyne, MD, Henry Wagner, Jr., MD, Patrick J Stiff, MD, Bruce D. Cheson, M.D., Douglas A. Stewart, MD, FRCPC, Brad S. Kahl, MD, Jonathan W. Friedberg, MD, Kristie A. Blum, MD, Thomas M. Habermann, MD, Joseph Tuscano, MD, Richard T. Hoppe, MD, Sandra J. Horning, MD, Ranjana H. Advani, MD
Journal: Blood
Blood (2013) 122 (21): 4277.
https://doi.org/10.1182/blood.V122.21.4277.4277
Published: 2013
Journal Articles

Safety Profile and Clinical Response To MEDI-551, a Humanized Monoclonal Anti-CD19, In a Phase 1/2 Study In Adults With Relapsed Or Refractory Advanced B-Cell Malignancies

Andres Forero-Torres, MD, Mehdi Hamadani, MD, Michelle A. Fanale, MD, Celeste M. Bello, MD, Thomas J. Kipps, MD, PhD, Fritz Offner, MD, Gregor Verhoef, Massimo Federico, MD, Stephanie A. Gregory, MD, Anne Sonet, MD, Sarit Assouline, MD, Jaime Pérez de Oteyza, Jose Francisco Tomas, MD, Antonio Cuneo, MD, Nairouz Elgeioushi, MPH, Trishna Goswami, MD, Ramy Ibrahim, MD, Ronald Herbst, PhD, Bruce D. Cheson, M.D.
Journal: Blood
Blood (2013) 122 (21): 1810.
https://doi.org/10.1182/blood.V122.21.1810.1810
Published: 2013
Journal Articles

Improved Risk Stratification With Addition Of Male Sex (S) To The Elderly International Prognostic Index (S-EIPI) For DLBCL Patients > 60 Years Treated With R-CHOP: An International Collaboration Of The US Intergroup, German High-Grade Non-Hodgkin Lymphoma Study Group and Groupe d’Etude De Lymphome d’Adultes

Ranjana H. Advani, MD, Fangxin Hong, PhD, Thomas M. Habermann, MD, Hailun Li, MS, Brad S. Kahl, MD, Vicki A. Morrison, MD, Edie A. Weller, PhD, Gaurav Varma, MSPH, Richard I Fisher, MD, Bruce A. Peterson, MD, Bruce D. Cheson, M.D., Randy D. Gascoyne, MD, Sandra J. Horning, MD, Sami Bousetta, Bertrand Coiffier, MD, PhD, Marita Ziepert, Michael Pfreundschuh, MD
Journal: Blood
Blood (2013) 122 (21): 3045.
https://doi.org/10.1182/blood.V122.21.3045.3045
Published: 2013
Journal Articles

Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance)

Greg Malnassy, MS, Susan Geyer, PhD, Noreen Fulton, B.S., Greg Koval, B.S., Donna Niedzwiecki, PhD, Victoria Carlton, PhD, Li Weng, PhD, Lawrence D. Kaplan, MD, Guido Marcucci, MD, Lloyd E Damon, MD, Richard A. Larson, MD, Richard M. Stone, MD, Bruce D. Cheson, M.D., Malek Faham, MD, PhD, Wendy Stock, M.D.
Journal: Blood
Blood (2013) 122 (21): 2547.
https://doi.org/10.1182/blood.V122.21.2547.2547
Published: 2013
Journal Articles

The Role Of Body Mass Index In Survival Outcome For Lymphoma Patients: US Intergroup Experience

Fangxin Hong, Ph.D., Thomas M Habermann, MD, Leo I. Gordon, MD, Howard S Hochster, MD, Randy D. Gascoyne, MD, Vicki A. Morrison, MD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Patrick J Stiff, MD, Bruce D. Cheson, M.D., Michael Crump, MD FRCPC, Sandra J. Horning, MD, Brad S. Kahl, MD
Journal: Blood
Blood (2013) 122 (21): 3060.
https://doi.org/10.1182/blood.V122.21.3060.3060
Published: 2013
Journal Articles

Phase II Study of Thalidomide in Escalating Doses for Follicular (F-NHL) and Small Lymphocytic Lymphoma (Sll): CALGB Study 50002.

David L. Grinblatt, M.D., Jeffrey Johnson, Donna Niedzwicki, Ph.D., David A. Rizzieri, M.D., Nancy Bartlett, M.D., Bruce D. Cheson, M.D.
Journal: Blood
Blood (2004) 104 (11): 3284.
https://doi.org/10.1182/blood.V104.11.3284.3284
Published: 2004